Vicki Wang
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Serotonergic Regulation of Synaptic Dopamine Levels Mitigates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease.
Journal: Journal of Parkinson's disease
Published: June 21, 2024
Targeting Rap1b signaling cascades with CDNF: Mitigating platelet activation, plasma oxylipins and reperfusion injury in stroke.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 16, 2024
Attenuating mitochondrial dysfunction and morphological disruption with PT320 delays dopamine degeneration in MitoPark mice.
Journal: Journal of biomedical science
Published: December 08, 2023
PT320, a Sustained-Release GLP-1 Receptor Agonist, Ameliorates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease.
Journal: International journal of molecular sciences
Published: January 15, 2023
Tetrabenazine Mitigates Aberrant Release and Clearance of Dopamine in the Nigrostriatal System, and Alleviates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease.
Journal: Journal of Parkinson's disease
Published: May 23, 2022
Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's Disease.
Journal: ACS pharmacology & translational science
Published: January 07, 2021
Post-stroke Delivery of Valproic Acid Promotes Functional Recovery and Differentially Modifies Responses of Peri-Infarct Microglia.
Journal: Frontiers in molecular neuroscience
Published: December 08, 2020
Delayed Dopamine Dysfunction and Motor Deficits in Female Parkinson Model Mice.
Journal: International journal of molecular sciences
Published: October 11, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026